About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Rxra
retinoid X receptor alpha
MGI:98214
165 phenotypes from 11 alleles in 11 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Myl2tm1(cre)Krc/Myl2+
Rxratm1Krc/Rxratm1Krc
involves: 129S4/SvJae * Black Swiss
no abnormal phenotype detected J:48085
Rxrapke/Rxrapke
C57BL/6J-Rxrapke
abnormal dendritic cell physiology J:103186
abnormal regulatory T cell physiology J:103186
abnormal T-helper 2 cell morphology J:103186
alopecia J:103186
cornea opacity J:103186
dermal cyst J:103186
diluted coat color J:103186
kyphosis J:103186
Rxratm1.1Krc/Rxratm1.1Krc
involves: 129S4/SvJae * Black Swiss
congestive heart failure J:48085
lethality throughout fetal growth and development, complete penetrance J:48085
Rxratm1.1Pcn/Rxratm1.1Pcn
involves: 129S2/SvPas * C57BL/6 * SJL
abnormal conotruncus septation J:146761
abnormal cornea stroma morphology J:146761
abnormal eyelid morphology J:146761
abnormal ocular fundus morphology J:146761
abnormal optic disk morphology J:146761
abnormal pharyngeal arch artery morphology J:146761
abnormal placenta labyrinth morphology J:146761
abnormal placenta morphology J:146761
absent Harderian gland J:146761
absent sclera J:146761
absent sublingual duct J:146761
decreased fetal size J:146761
decreased ventral retina size J:146761
lethality throughout fetal growth and development, incomplete penetrance J:146761
perinatal lethality, complete penetrance J:146761
persistent hyperplastic primary vitreous J:146761
ventral rotation of lens J:146761
ventricular myocardium compact layer hypoplasia J:146761
Rxratm1Ipc/Rxratm1Ipc
involves: 129S2/SvPas
abnormal epidermis stratum corneum morphology J:109090
abnormal keratinocyte morphology J:109090
abnormal skin condition J:109090
abnormal skin morphology J:109090
lethality throughout fetal growth and development, complete penetrance J:60351
ventricular hypoplasia J:60351
Rxratm1Ipc/Rxratm1Ipc
Tg(Myh6-Rxra)41Pcn/0
involves: 129S2/SvPas
lethality throughout fetal growth and development, complete penetrance J:60351
ventricular hypoplasia J:60351
Rxratm1Ipc/Rxratm2Ipc
involves: 129S2/SvPas * C57BL/6
abnormal eye development J:146761
Rxratm1Krc/Rxra+
Tg(Pbsn-cre)4Prb/0
involves: 129S4/SvJae * C57BL/6 * DBA/2
abnormal prostate gland branching morphogenesis J:78553
increased prostate intraepithelial neoplasia incidence J:78553
prostate gland epithelial hyperplasia J:78553
Rxratm1Krc/Rxratm1Krc
Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6
abnormal kidney morphology J:168799
abnormal macrophage activation involved in immune response J:168799
abnormal nephron morphology J:168799
abnormal peritoneal macrophage morphology J:168799
abnormal podocyte foot process morphology J:168799
abnormal renal glomerulus morphology J:168799
albuminuria J:168799
enlarged kidney J:168799
expanded mesangial matrix J:168799
fused podocyte foot processes J:168799
glomerulonephritis J:168799
impaired macrophage phagocytosis J:168799
increased anti-double stranded DNA antibody level J:168799
increased anti-nuclear antigen antibody level J:168799
increased anti-single stranded DNA antibody level J:168799
increased autoantibody level J:168799
increased circulating creatine level J:168799
increased IgG level J:168799
increased IgM level J:168799
increased kidney weight J:168799
increased mesangial cell number J:168799
increased renal glomerulus apoptosis J:168799
increased renal glomerulus basement membrane thickness J:168799
increased urine protein level J:168799
renal glomerulus hypertrophy J:168799
Rxratm1Krc/Rxratm1Krc
Tg(Pbsn-cre)4Prb/0
involves: 129S4/SvJae * C57BL/6 * DBA/2
abnormal prostate gland branching morphogenesis J:78553
abnormal prostate gland physiology J:78553
increased prostate intraepithelial neoplasia incidence J:78553
Rxratm1Rev/Rxra+
involves: 129S4/SvJae * C57BL/6
abnormal atrioventricular valve morphology J:35363
abnormal heart development J:35363
abnormal heart ventricle morphology J:35363
abnormal interventricular septum morphology J:35363
abnormal mitral valve morphology J:35363
abnormal myocardial trabeculae morphology J:35363
abnormal myocardium compact layer morphology J:35363
abnormal myocardium layer morphology J:35363
abnormal tricuspid valve morphology J:35363
abnormal ventricle papillary muscle morphology J:35363
decreased heart left ventricle wall thickness J:35363
decreased heart right ventricle wall thickness J:35363
double outlet right ventricle J:35363
mitral valve stenosis J:35363
pulmonary artery stenosis J:35363
thin ventricular wall J:35363
Rxratm1Rev/Rxratm1Rev
involves: 129S4/SvJae * C57BL/6
abnormal atrioventricular cushion morphology J:35363
abnormal conotruncal ridge morphology J:35363
abnormal heart left atrium morphology J:65904
abnormal heart morphology J:65904
abnormal heart ventricle shape J:18047, J:65904
abnormal mitral valve morphology J:35363
abnormal myocardial trabeculae morphology J:35363
abnormal myocardium compact layer morphology J:18047
abnormal myocardium layer morphology J:18047, J:35363
abnormal pericardial cavity morphology J:18047
abnormal pericardium morphology J:18047
abnormal tricuspid valve morphology J:35363
abnormal truncus arteriosus septation J:18047
abnormal ventricle papillary muscle morphology J:35363
aortopulmonary window J:35363
atrioventricular block J:65904
complete atrioventricular septal defect J:35363
congestive heart failure J:18047, J:65904
decreased cardiac output J:65904
decreased heart rate J:65904
decreased hepatocyte proliferation J:18047
decreased ventricle muscle contractility J:65904
delayed hepatic development J:18047
dilated heart right atrium J:18047
dilated heart right ventricle J:18047
double outlet right ventricle J:35363
failure of atrioventricular cushion closure J:35363
heart block J:65904
lethality throughout fetal growth and development, complete penetrance J:18047
mitral valve atresia J:18047
muscular ventricular septal defect J:18047, J:35363, J:65904
persistent truncus arteriosus J:35363
skin edema J:18047
small liver J:18047
thin ventricular wall J:18047, J:35363
trabecula carnea hypoplasia J:18047
translucent skin J:18047
ventricular hypoplasia J:18047
ventricular myocardium compact layer hypoplasia J:35363
Rxratm2Ipc/Rxra+
involves: 129
abnormal postnatal growth/weight/body size J:20550
Rxratm2Ipc/Rxratm2Ipc
involves: 129
abnormal cardiovascular system morphology J:20550
abnormal cricoid cartilage morphology J:42773
abnormal extraembryonic tissue morphology J:44230
abnormal eye morphology J:20550
prenatal lethality J:20550
Rxratm2Ipc/Rxratm4.1Ipc
involves: 129
abnormal eye development J:67149
abnormal vasculogenesis J:67149
edema J:67149
lethality throughout fetal growth and development, complete penetrance J:67149
pallor J:67149
Rxratm2Ipc/Rxratm4Ipc
Tg(KRT14-cre)1Ipc/0
involves: 129S2/SvPas * C57BL/6 * SJL
abnormal hair cycle anagen phase J:67149
abnormal hair cycle telogen phase J:67149
abnormal hair follicle melanin granule distribution J:67149
abnormal hair follicle morphology J:67149
abnormal hair growth J:67149
abnormal Langerhans cell morphology J:67149
abnormal melanosome morphology J:67149
abnormal piliary canal morphology J:67149
abnormal skin morphology J:67149
alopecia J:67149
delayed hair appearance J:67149
dermal cyst J:67149
dilated piliary canal J:67149
diluted coat color J:67149
disorganized outer root sheath cells J:67149
distorted hair follicle pattern J:67149
hair follicle degeneration J:67149
hyperkeratosis J:67149
increased keratinocyte proliferation J:67149
scaly skin J:67149
skin inflammation J:67149
skin lesions J:67149
thick dermal layer J:67149
thick epidermis suprabasal layer J:67149
thin hypodermis J:67149
Rxratm3Ipc/Rxratm3Ipc
involves: 129 * C57BL/6
abnormal axial skeleton morphology J:69853
abnormal cardiovascular system morphology J:69853
abnormal digit morphology J:69853
abnormal eye morphology J:69853
abnormal postnatal growth/weight/body size J:69853
abnormal skeleton development J:69853
normal behavior/neurological phenotype J:69853
postnatal lethality, incomplete penetrance J:69853
Rxratm4.1Ipc/Rxratm4.1Ipc
involves: 129S2/SvPas
abnormal eye development J:67149
abnormal vasculogenesis J:67149
edema J:67149
lethality throughout fetal growth and development, complete penetrance J:67149
pallor J:67149
Rxratm4Ipc/Rxratm4Ipc
Tg(KRT14-cre)1Ipc/0
involves: 129S2/SvPas * C57BL/6 * SJL
abnormal epidermis stratum corneum morphology J:109090
abnormal keratinocyte morphology J:109090
shiny skin J:109090
Rxratm4Ipc/Rxratm4Ipc
Tg(Tyrp1-cre)1Ipc/0
involves: 129S2/SvPas
abnormal cone electrophysiology J:88451
abnormal photoreceptor outer segment morphology J:88451
abnormal retina outer nuclear layer morphology J:88451
abnormal retina pigment epithelium morphology J:88451
abnormal retina pigmentation J:88451
abnormal rod electrophysiology J:88451
decreased retina photoreceptor cell number J:88451
delayed dark adaptation J:88451
disorganized photoreceptor outer segment J:88451
retina pigment epithelium atrophy J:88451
short photoreceptor outer segment J:88451
Tg(Myh6-Rxra)41Pcn/0
Not Specified
abnormal cardiac thrombosis J:60351
abnormal M line morphology J:60351
abnormal myocardial fiber morphology J:60351
abnormal respiratory electron transport chain J:60351
abnormal sarcomere morphology J:60351
abnormal Z line morphology J:60351
dilated cardiomyopathy J:60351
enlarged heart J:60351
myocardial fiber degeneration J:60351
pleural effusion J:60351
premature death J:60351

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory